子宫内膜癌中应用SPECT/CT与γ探针进行前哨淋巴结定位:影响检出率的参数分析
该研究纳入2011至2016年间在本机构接受术前前哨淋巴结(SLN)定位的145例连续子宫内膜癌(EC)患者,宫颈周围注射锝-99m-纳米胶体后行腹部和盆腔SPECT/CT。SPECT/CT共识别282枚SLN,术前与术中SLN检出率分别为86%、76%和74%。SPECT/CT上出现骨髓摄取是与SLN检出失败相关的最重要因素(p=0.005),腹膜/腹部放射性也与SPECT/CT漏检SLN相关(p=0.02)。
要点
- SPECT/CT上骨髓摄取是 scintigraphic SLN 检出失败的最重要相关因素(p=0.005)。
- 腹膜/腹部放射性也与SPECT/CT漏检SLN相关(p=0.02),而单独肝/脾摄取不预测检出失败。
- SPECT/CT检出SLN数量少与年龄较大及注射活度较低轻度相关。
核心结论
- 静脉引流(表现为骨髓摄取)是与闪烁显像SLN检出失败相关的最重要因素。
- 较高的腹膜和腹部放射性也与检出失败相关。
- 因此,在EC中细致地应用放射性示踪剂至关重要。
研究设计与样本
- 本研究为在本机构开展的回顾性分析(原文未明确写回顾性,按原文照录为分析),纳入2011年至2016年间在本机构接受术前SLN定位的145例连续EC患者。
- 所有患者宫颈周围注射锝-99m-纳米胶体(平均230±45 MBq),注射后平均4:20±1:20小时采集腹部和盆腔SPECT/CT,次日行手术分期。
- 收集采集参数、患者特征、SPECT/CT表现及组织病理学结果。
主要发现
- SPECT/CT共识别282枚SLN,术前和术中SLN检出率分别为86%、76%和74%。
- 与SLN检出失败相关的最重要因素是SPECT/CT上出现骨髓摄取(p=0.005)。
- 腹膜/腹部放射性也与SPECT/CT漏检SLN相关(p=0.02),而单独肝/脾摄取不预测检出失败。
- SPECT/CT检出SLN数量少与年龄较大和注射活度较低轻度相关。
- 肿瘤组织学类型和分期、淋巴结受累及注射至显像时间间隔对检出率无显著影响。
关键数值与推荐
- 注射锝-99m-纳米胶体平均活度为230±45 MBq。
- 注射至SPECT/CT采集平均时间为4:20±1:20小时。
- 术前和术中SLN检出率分别为86%、76%和74%。
- 骨髓摄取与检出失败的关联p=0.005;腹膜/腹部放射性与SPECT/CT漏检SLN的关联p=0.02。
临床怎么用
- 原文结论强调在EC中 meticulous 应用放射性示踪剂至关重要,以避免静脉引流和腹膜/腹部放射性导致的SLN检出失败。
- 原文未据此给出具体的临床操作推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: SPECT/CT after pericervical injection of technetium-99 m-nanocolloid was shown to be suitable for sentinel lymph node (SLN) mapping in endometrial cancer (EC). The aim of this study was to analyze factors affecting successful SLN detection by means of SPECT/CT such as imaging findings, patient characteristics and tumor biology in a large cohort of patients. METHODS: One hundred and forty-five consecutive patients suffering from EC who received pre-surgical SLN mapping at our institution between 2011 and 2016 were included in this analysis. SPECT/CT data of abdomen and pelvis (mean 4:20 ± 1:20 h p.i.) were acquired after pericervical injection of technetium-99 m-nanocolloid (mean 230 ± 45 MBq) in all patients. Surgical staging was performed on the day after. Acquisition parameters, patient characteristics, SPECT/CT findings as well as histopathological results were collected. RESULTS: A total of 282 SLNs were identified by means of SPECT/CT. Overall, preoperative and intraoperative SLN detection rates were 86%, 76% and 74% respectively. The most important factor associated with failure to detect SLNs was the presence of high bone marrow on SPECT/CT (p = 0.005). Peritoneal/abdominal radioactivity was also associated with missed SLN detection in SPECT/CT (p = 0.02). However, the presence of liver/spleen uptake on its own was not predictive for detection failure. Low numbers of detected SLNs in SPECT/CT were slightly related with older age and lower injected activity. No significant influence was found for the parameters of tumor histology and stage, lymph node involvement and the time gap between injection and imaging. CONCLUSIONS: Venous drainage as indicated by bone marrow uptake is the most important factor associated with scintigraphic SLN detection failure. Moreover, high peritoneal and abdominal activity was also associated with detection failure. Thus, meticulous application of the radiotracer is crucial in EC.
引用
- Sahbai S, Taran FA, Staebler A, et al. Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate. Eur J Nucl Med Mol Imaging. 2017. PMID: 28374119. doi:10.1007/s00259-017-3692-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。